APA (7th ed.) Citation

B, B., SD, L., P, P., K, F., J, K., Y, W., . . . HK, E. (2025). Identification of HIF1A as a therapeutic target during SARS-CoV-2-associated lung injury. JCI insight, 10(14), . https://doi.org/10.1172/jci.insight.191463

Chicago Style (17th ed.) Citation

B, Bobrow, et al. "Identification of HIF1A as a Therapeutic Target During SARS-CoV-2-associated Lung Injury." JCI Insight 10, no. 14 (2025). https://doi.org/10.1172/jci.insight.191463.

MLA (9th ed.) Citation

B, Bobrow, et al. "Identification of HIF1A as a Therapeutic Target During SARS-CoV-2-associated Lung Injury." JCI Insight, vol. 10, no. 14, 2025, https://doi.org/10.1172/jci.insight.191463.